The genomics of inherited bone marrow failure: from mechanism to the clinic

98Citations
Citations of this article
164Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The inherited bone marrow failure syndromes (IBMFS) typically present with significant cytopenias in at least one haematopoietic cell lineage that may progress to pancytopenia, and are associated with increased risk of cancer. Although the clinical features of the IBMFS are often diagnostic, variable disease penetrance and expressivity may result in diagnostic dilemmas. The discovery of the genetic aetiology of the IBMFS has been greatly facilitated by next-generation sequencing methods. This has advanced understanding of the underlying biology of the IBMFS and been essential in improving clinical management and genetic counselling for affected patients. Herein we review the clinical features, underlying biology, and new genomic discoveries in the IBMFS, including Fanconi anaemia, dyskeratosis congenita, Diamond Blackfan anaemia, Shwachman Diamond syndrome and some disorders of the myeloid and megakaryocytic lineages.

Cite

CITATION STYLE

APA

Wegman-Ostrosky, T., & Savage, S. A. (2017, May 1). The genomics of inherited bone marrow failure: from mechanism to the clinic. British Journal of Haematology. Blackwell Publishing Ltd. https://doi.org/10.1111/bjh.14535

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free